MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Idera Pharmaceuticals Company Profile (NASDAQ:IDRA)

Consensus Ratings for Idera Pharmaceuticals (NASDAQ:IDRA) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (345.21% upside)

Analysts' Ratings History for Idera Pharmaceuticals (NASDAQ:IDRA)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016WedbushInitiated CoverageOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015JPMorgan Chase & Co.Initiated CoverageOverweight$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Idera Pharmaceuticals (NASDAQ:IDRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/9/2016Q1($0.11)($0.11)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q4($0.11)($0.10)$20.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315($0.11)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.11)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q1($0.11)($0.12)$0.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.11)($0.14)$0.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q314($0.11)($0.11)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.09)($0.10)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.08)($0.12)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q4($0.08)($0.10)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/14/2013Q3($0.11)($0.11)$0.03 million$0.01 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2013Q213($0.12)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/15/2013Q113($0.19)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2013Q4 2012($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2012Q312($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Idera Pharmaceuticals (NASDAQ:IDRA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.11)($0.10)($0.11)
Q2 20161($0.11)($0.11)($0.11)
Q3 20162($0.11)($0.09)($0.10)
Q4 20162($0.10)($0.09)($0.10)
(Data provided by Zacks Investment Research)
Dividend History for Idera Pharmaceuticals (NASDAQ:IDRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Idera Pharmaceuticals (NASDAQ:IDRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016James A GeraghtyDirectorBuy10,000$1.34$13,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Mark J CaseyVPBuy34,450$1.44$49,608.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Vincent MilanoCEOBuy40,000$1.97$78,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Julian BakerDirectorBuy5,333,333$3.75$19,999,998.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Youssef El ZeinDirectorSell100,000$3.68$368,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Vincent MilanoCEOBuy200,000$4.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014James A GeraghtyDirectorBuy10,000$2.65$26,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013James A GeraghtyDirectorBuy40,000$2.72$108,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013James A GeraghtyDirectorBuy60,000$1.90$114,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013James A GeraghtyDirectorBuy300,000$1.75$525,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013C Keith HartleyDirectorBuy90,000$0.49$44,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Idera Pharmaceuticals (NASDAQ:IDRA)
DateHeadline
06/28/16 04:31 PMIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 04:34 PMIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Sellers Increased By 2.89% Their Shorts - Press Telegraph
06/25/16 08:25 AMStrong Sell Calls Recommendations For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) At 0 - Investor Newswire
06/23/16 07:29 AMBrokers Issue Average Price Target Of 6.33 On Idera Pharmaceuticals, Inc. (IDRA) - Fiscal Standard
06/20/16 04:23 PMThis Weeks Broker Views For Idera Pharmaceuticals, Inc. (IDRA) - Fiscal Standard
06/19/16 04:09 PMStrong Buy Calls Count For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) At 3 - Investor Newswire
06/18/16 08:58 AMStrong Buy Calls Count For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) At 4 - Investor Newswire
06/17/16 08:07 AMIDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/17/16 07:19 AMIdera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3% - Nasdaq
06/17/16 07:19 AMIdera Pharmaceuticals Inc. (IDRA) Jumps 8.33% on June 16 - Equities.com
06/17/16 03:41 AMIdera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3% -
06/08/16 09:52 AMForget Biogen (BIIB), Buy These 5 Biotech Stocks Instead -
06/07/16 04:39 PMETF’s with exposure to Idera Pharmaceuticals, Inc. : June 7, 2016 -
06/07/16 08:08 AMIdera to Present at Two June Investor Healthcare Conferences - [at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., June 07, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
06/03/16 07:17 AMNotable Moving HC Stocks: Johnson & Johnson (NYSE:JNJ), Idera Pharmaceuticals Inc (NASDAQ:IDRA) - share market updates (press release) - Notable Moving HC Stocks: Johnson & Johnson (NYSE:JNJ), Idera Pharmaceuticals Inc (NASDAQ:IDRA)share market updates (press release)Shares of Johnson & Johnson (NYSE:JNJ) ended Thursday session in green amid volatile trading. The shares closed up +1.63 points or 1.45% at $114.41 with 7.31 million shares getting traded. Post opening the session at $112.87, the shares hit an intraday ...and more »
06/02/16 04:51 PMIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Yearly Accrued Expenses At $4.274 Millions - Stocks Daily - Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Yearly Accrued Expenses At $4.274 MillionsStocks DailyFor the year closed 2015-12-31 Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) had beginning cash of $19.971 millions. This figure was $19.971 millions for the three-month period ended 2015-12-31. Cash balance was $60.16 millions for the fiscal closed ...Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Posts Quarterly EPS Of $-0.1057 From Continuing OperationsEnterprise Leaderall 3 news articles »
06/02/16 07:19 AMBuy, Sell Or Hold Rating For Idera Pharmaceuticals, Inc. (IDRA)? - Share Trading News - Buy, Sell Or Hold Rating For Idera Pharmaceuticals, Inc. (IDRA)?Share Trading News01/06/2016 – Wedbush began new coverage on Idera Pharmaceuticals, Inc. giving the company a “outperform” rating. They now have a USD 6 price target on the stock. 12/07/2015 – Idera Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at ...and more »
06/01/16 04:51 PMInsiders Are Gradually Buying Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - HNN - Insiders Are Gradually Buying Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)HNNAccording to the latest SEC filings, insiders at Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) have increased their position in the stock by 7.48% over the past 6 months. Insiders now own 1.00% of total outstanding shares. There are both legal and illegal ...and more »
06/01/16 07:18 AMIdera Pharmaceuticals Inc. (IDRA) Jumps 6.04% on May 31 - Equities.com - Idera Pharmaceuticals Inc. (IDRA) Jumps 6.04% on May 31Equities.comIdera Pharmaceuticals Inc. (IDRA) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 6.04% to $1.58, representing a gain of $0.09 per share. Some 481,012 shares traded hands on 2,063 trades, compared with an ...and more »
05/31/16 04:45 PMIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Quarterly EPS Estimate At $-0.12 - Investor Newswire - Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Quarterly EPS Estimate At $-0.12Investor NewswireFirst Call stated that Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) can touch $5.00 in coming one year. For the next quarter, the per-share earnings target is $-0.12 and for ongoing fiscal at $-0.45. EPS target for next year is $-0.46 versus the mean EPS ...and more »
05/31/16 08:59 AMStock Review and Earnings Check on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - HNN - Stock Review and Earnings Check on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Idera Pharmaceuticals, Inc.and more »
05/26/16 07:14 PMIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Impact Score At 94 - Stocks Daily - Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Impact Score At 94Stocks DailyAlpha One explored various online articles released on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the ...and more »
05/25/16 06:55 PMInsiders Are Gradually Buying Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Wall Street Hints and News - Insiders Are Gradually Buying Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) have increased their position in the stock by 7.82% over the past 6 months. Insiders now own 1.00% of total outstanding shares. There are both legal and illegal ...and more »
05/25/16 12:30 AMIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Short Interest Decreased By 7.99% - Wall Street Hints and News - Idera Pharmaceuticals Incorporated (NASDAQ:IDRA) Short Interest Decreased By 7.99%Wall Street Hints and NewsThe short interest to Idera Pharmaceuticals Incorporated's float is 11.62%. The stock increased 4.58% or $0.07 during the last trading session, hitting $1.6. About 482,436 shares traded hands. Idera Pharmaceuticals Inc (NASDAQ:IDRA) has declined 49.37% ...
05/21/16 12:06 AMValuable Price Trends to Observe: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , Impax Laboratories, Inc. (NASDAQ ... - Street Updates - Valuable Price Trends to Observe: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , Impax Laboratories, Inc. (NASDAQ ...Street UpdatesIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) diminished -2.74%, closing at $1.42 after floating between $1.40 and $1.48. The company has market capitalization of $172.27M. It has twelve month low of $1.19 and twelve month high of $4.42. The recent traded ...and more »
05/19/16 06:34 PMETF’s with exposure to Idera Pharmaceuticals, Inc. : May 19, 2016 -
05/19/16 12:12 AMRevenue Update on Idera Pharmaceuticals Inc(NASDAQ:IDRA) - Trade Calls - Revenue Update on Idera Pharmaceuticals Inc(NASDAQ:IDRA)Trade CallsIdera Pharmaceuticals Inc(NASDAQ:IDRA) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 9, 2016. Company reported revenue of $294.00K. Analysts estimated a revenue of $90.00K. Earnings per ...
05/18/16 11:27 AMIdera Pharmaceuticals Inc (NASDAQ:IDRA) EPS analysis - News Oracle - Idera Pharmaceuticals Inc (NASDAQ:IDRA) EPS analysisNews OracleBy looking at Idera Pharmaceuticals Inc (NASDAQ:IDRA) YTD (year to date) performance, the stock shows Negative value of -54.05%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock ...and more »
05/18/16 10:57 AMIdera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 06:45 PMInvestors Targeted Stocks: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , Oncothyreon Inc. (NASDAQ:ONTY) - Street Updates - Investors Targeted Stocks: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , Oncothyreon Inc. (NASDAQ:ONTY)Street UpdatesOn 5/13/2016, shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) rose +4.55% in trading session and finally closed at $1.38. The company most recent volume stood at 727.52 thousand shares as compared to its average volume of 1.05 million shares.Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Hovering Around $1.38Equities FocusWarning Idera Pharmaceuticals Inc (NASDAQ:IDRA) pessimists! James Geraghty just Invested in 10000 shares.The PostLatest Analyst Reports On Idera Pharmaceuticals, Inc.Risers & FallersMarkets Daily -Wall Street Hints and News -Analyst Ratingsall 7 news articles »
05/17/16 06:45 PMIdera Pharmaceuticals Inc. (IDRA) Jumps 6.52% on May 16 - Equities.com - Idera Pharmaceuticals Inc. (IDRA) Jumps 6.52% on May 16Equities.comIdera Pharmaceuticals Inc. (IDRA) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 6.52% to $1.47, representing a gain of $0.09 per share. Some 664,324 shares traded hands on 2,148 trades, compared with an ...
05/17/16 11:13 AMShare Recap and Earnings Focus on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Wall Street Hints and News - Share Recap and Earnings Focus on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)Wall Street Hints and NewsPresently, covering analysts are anticipating Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) to report quarterly EPS of $-0.11. The company's next earnings report is expected to be released on or around 2016-08-04 for the period ending on 2016-06-30.and more »
05/17/16 11:13 AMHC Sector update: Exelixis, Inc. (NASDAQ:EXEL), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Intuitive Surgical, Inc ... - share market updates (press release) - share market updates (press release)HC Sector update: Exelixis, Inc. (NASDAQ:EXEL), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Intuitive Surgical, Inc ...share market updates (press release)Shares of Exelixis, Inc. (NASDAQ:EXEL) ended Monday session in red amid volatile trading. The shares closed down -0.12 points or -2.14% at $5.49 with 6.48 million shares getting traded. Post opening the session at $5.58, the shares hit an intraday low ...and more »
05/14/16 12:33 AMIdera Pharmaceuticals : Reports First Quarter 2016 Financial Results and Provides Corporate Update - CAMBRIDGE, Mass. and EXTON, Pa., May 09, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic acid-based therapeutics for ...
05/13/16 02:58 AMIdera Presents Preclinical Data Demonstrating Enhanced Systemic Anti-Tumor Activity from Combination Treatment with Intra-tumoral IMO-2125 and IDO-1 Inhibitor at AACR Annual Meeting 2016 - [at noodls] - CAMBRIDGE, Mass. and EXTON, Pa., April 19, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
05/12/16 07:52 PMHC Stocks Development: Inovio Pharmaceuticals Inc (INO), Allergan plc (AGN), Idera Pharmaceuticals Inc (IDRA) - share market updates (press release) - share market updates (press release)HC Stocks Development: Inovio Pharmaceuticals Inc (INO), Allergan plc (AGN), Idera Pharmaceuticals Inc (IDRA)share market updates (press release)Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) ended Wednesday session in green amid volatile trading. The shares closed up +0.11 points or 1.17% at $9.49 with 1.02 million shares getting traded. Post opening the session at $9.41, the shares hit an ...and more »
05/12/16 07:52 PMHave a Glance at: Idera Pharmaceuticals Inc (NASDAQ:IDRA) - The Point Review - The Point ReviewHave a Glance at: Idera Pharmaceuticals Inc (NASDAQ:IDRA)The Point ReviewShare of Idera Pharmaceuticals Inc (NASDAQ:IDRA) traded on -8.97 percent below secure line at 3:42PM EDT in order to take the company's stock at the price of $1.32. At the time of writing the stock exchanged hands 692,409 shares versus average trading ...and more »
05/11/16 07:49 PMEarnings Trends of the Stock: Idera Pharmaceuticals Inc (NASDAQ:IDRA) - News Oracle - News OracleEarnings Trends of the Stock: Idera Pharmaceuticals Inc (NASDAQ:IDRA)News OracleLast Trade: The Company rose 2.16% and finished at $1.42. The daily volume was measured at 2.59 million shares. The 52-week high of the share price is $4.42 and the 52-week low is $1.19. The company has a market cap of $174.77 million. Its latest ...and more »
05/11/16 12:45 AMBiotech Stocks to Lookout: CytRx Corporation (NASDAQ:CYTR), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Novavax ... - The Point Review - The Point ReviewBiotech Stocks to Lookout: CytRx Corporation (NASDAQ:CYTR), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Novavax ...The Point ReviewShares of Idera Pharmaceuticals Inc (NASDAQ:IDRA) slipped -6.83% to $1.29 at 12:49 PM EDT. The stock exchanged hands of 860,553 shares recently versus average trading capacity of 1.13 million shares. However recently the stock touch highest trading ...and more »
05/11/16 12:45 AMIdera Pharmaceuticals' (IDRA) Buy Rating Reiterated at Cowen and Company - Washington News Wire - Washington News WireIdera Pharmaceuticals' (IDRA) Buy Rating Reiterated at Cowen and CompanyWashington News WireIdera Pharmaceuticals Inc (NASDAQ:IDRA)'s stock had its “buy” rating reissued by equities researchers at Cowen and Company in a research report issued on Tuesday, Analyst Ratings Network.com reports. A number of institutional investors recently added ...Idera Pharmaceuticals Inc (NASDAQ:IDRA) Given $5.33 Average Target Price by AnalystsNewsWay 21Idera Pharmaceuticals, Inc. (IDRA) Updated Broker RatingsRisers & FallersEarnings Expectations of the Stock: Idera Pharmaceuticals (IDRA)News OracleSonoran Weekly Review -Equities Focusall 14 news articles »
05/10/16 07:29 PMNotable Moving HC Stocks: RXi Pharmaceuticals Corp (RXII), Idera Pharmaceuticals Inc (IDRA), Allergan plc (AGN) - share market updates (press release) - Notable Moving HC Stocks: RXi Pharmaceuticals Corp (RXII), Idera Pharmaceuticals Inc (IDRA), Allergan plc (AGN)share market updates (press release)Shares of RXi Pharmaceuticals Corp (NASDAQ:RXII) ended Monday session in red amid volatile trading. The shares closed down -0.16 points or -9.14% at $1.59 with 101,811.00 shares getting traded. Post opening the session at $1.69, the shares hit an ...and more »
05/09/16 04:00 PMIdera Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today -
05/09/16 03:45 PMIdera reports 1Q loss -
05/09/16 03:42 PMIDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report -
05/09/16 03:00 PMIdera Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update - [GlobeNewswire] - 9 of 10 Waldenstrom’ s Macroglobulinemia Patients Treated at the Highest Dose h ave Demonstrated Reduction s in IgM or M-Protein Levels in Ongoing Trial. Company is on Track to Deliver D ata f rom 4 Clinical ...
05/09/16 06:07 AMQ1 2016 Idera Pharmaceuticals Inc Earnings Release - After Market Close -
05/08/16 09:01 PMNext Weeks Broker Price Targets For Idera Pharmaceuticals, Inc. (IDRA) - Share Trading News - Next Weeks Broker Price Targets For Idera Pharmaceuticals, Inc. (IDRA)Share Trading News01/06/2016 – Wedbush began new coverage on Idera Pharmaceuticals, Inc. giving the company a “outperform” rating. They now have a USD 6 price target on the stock. 12/07/2015 – Idera Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at ...
05/06/16 07:29 PMYesterday Biggest Movers: Bristol-Myers Squibb Company (NYSE:BMY) , Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Is stories - Yesterday Biggest Movers: Bristol-Myers Squibb Company (NYSE:BMY) , Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)Is storiesIn most recently trading session on 5/5/2016, Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) dropped -10.07% while traded on 1.76 million shares versus it's an average volume of 967.86 thousand shares. The company recorded the last trade with the price of ...and more »
05/06/16 07:29 PMEarnings Report of the Stock: Idera Pharmaceuticals Inc (NASDAQ:IDRA) - News Oracle - Earnings Report of the Stock: Idera Pharmaceuticals Inc (NASDAQ:IDRA)News OracleLast Trade: The Company fell -10.07% and finished at $1.34. The daily volume was measured at 1.76 million shares. The 52-week high of the share price is $4.42 and the 52-week low is $1.46. The company has a market cap of $167.42 million. Its latest ...and more »
05/06/16 01:30 AMActive biotech company shares in the news: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Inovio Pharmaceuticals, Inc ... - Street Register - Active biotech company shares in the news: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Inovio Pharmaceuticals, Inc ...Street RegisterIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) share price decreased to $1.49 each in the last trading session compared to a prior closing price of $1.66. The last closing price is -21.64% below its 20-day moving average and -44.71% below its 50-day moving ...and more »
About Idera Pharmaceuticals

Idera Pharmaceuticals logoIdera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The Company's drug candidates include IMO-8400; IMO-2125/IMO-2055, and IMO-9200. The Company's TLR antagonist lead drug candidates are IMO-8400 and IMO-9200, which are both antagonists of TLR7, TLR8 and TLR9. Its TLR agonist lead drug candidates are IMO-2055 and IMO-2125, which are both agonists of TLR9.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IDRA
  • CUSIP:
Key Metrics:
  • Previous Close: $1.46
  • 50 Day Moving Average: $1.50
  • 200 Day Moving Average: $1.95
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $177.12M
  • Current Quarter EPS Consensus Estimate: $-0.45 EPS
Additional Links:
Idera Pharmaceuticals (NASDAQ:IDRA) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha